Sharma et al.
JOCArticle
in the range of 10-20 nm. Different heights were observed
probably due to piling of individual rods as aggregates at
1 mM concentration.
stirred at 0 °C under N2 atmosphere for 15 min, treated with the
above crude amine 2 and DIPEA (0.50 mL, 2.90 mmol), and
stirred at room temperature for 5 h. The reaction mixture was
quenched with satd aq NH4Cl (10 mL) at 0 °C and diluted with
CHCl3 (10 mL). It was sequentially washed with 1 N HCl
(10 mL), water (10 mL), and aq NaCl solution (10 mL). The
organic layer was dried (Na2SO4) and evaporated to give the
residue, which was purified by column chromatography
(60-120 mesh silica gel, 50% ethyl acetate and petroleum ether)
Both TEM and AFM techniques, in spite of the use of two
different substrates (Cu/Rh grid and mica respectively),
provide equivalent nanorod structures. As depicted in
Figure 6, intermolecular association of macrocyles give rise
to nanostructured rods at 1 mM concentration. The surfaces
of these assemblies appear smooth and uniform throughout
the length, which suggests that the rods are made up of tens
of tightly packed peptide nanorods aligned parallel to each
other. Based on a “hierarchical” process proposed by Dory
and co-workers,20 it is believed that it involves an assembly of
individual peptide nanorods over several generations to end
up in the formation of nano- to micro- structured rods, which
most probably happens due to noncovalent interactions
among the nanorods.
to afford 3 (0.62 g, 67%) as a white solid: mp 95-96 °C; [R]D
=
þ86.6 (c 0.26, CHCl3); IR (KBr) 3267, 2988, 2930, 1751, 1736,
1
1670, 1660, 1550, 1168, 1055, 1021, 889, 855 cm-1 ; H NMR
(500 MHz, CDCl3) δ 9.34 (s, 1H, NH-2), 5.90 (d, J = 3.9 Hz, 1H,
C1H-1), 5.11 (br, 1H, NH-1), 4.58 (d, J = 3.9 Hz, 1H, C2H-1),
4.51 (q, J = 7.2 Hz, 1H, CRH-2), 4.31 (m, 1H, CβH-1), 4.23
(m, 2H, -CH2), 4.10 (br, 1H, C4H-1), 3.76 (br, 1H, C3H-1), 3.41
(s, 3H, OCH3-1), 2.54 (dd, J = 5.8, 15.0 Hz, 1H, CRH(pro-S)-1),
2.39 (dd, J = 5.0, 15.0 Hz, 1H, CRH(pro-R)-1), 1.66 (d, J =
7.2 Hz, 3H, CβH-2), 1.50, 1.48 (2s, 6H, Acetonide-CH3), 1.43
(s, 9H, BOC), 1.31 (t, J = 7.2 Hz, 3H, -CH3); 13C NMR
(150 MHz, CDCl3, 278 K): δ 172.0, 168.1, 156.0, 111.8, 104.6,
83.8, 81.2, 80.0, 79.6, 79.2, 61.3, 57.3, 47.6, 36.0, 28.2, 26.7, 26.2,
Conclusions
The present study demonstrates that, unlike the peptides
from (R)-β-Caa/(R)-Ama, (S)-β-Caa/(R)-Ama can easily
be cyclized. NMR and mass spectral studies reveal that the
symmetric cyclic peptide 5, with two N-O turns, shows
selective and appreciable binding affinity with the chloride
ion, while the linear tetrapeptide 4 does not display this
capability. NMR studies as a function of solute concentration
provide ample support of the intermolecular H-bonding,
which results in the nanomolecular assembly of these cyclic
peptides explored in detail by TEM and the AFM studies.
This new class of pseudo β2- and β3-peptides from (S)-β-Caa
and (R)-Ama mayaid in the designof diverse peptide scaffolds
with desired functional features.
16.2, 14.1; HRMS (ESIþ) m/z calcd for C21H36N2O10 (Mþ
þ
Na) 499.2267, found 499.2256.
Boc-(S)-β-Caa-(R)-Ama-(S)-β-Caa-(R)-Ama-OEt (4). A so-
lution of 3 (0.2 g, 0.42 mmol) as described for 7 gave Boc-(S)-
β-Caa-(R)-Ama-OH (9; 0.17 g, 90%) as a white solid, which was
used for further reaction without any purification.
A solution of 3 (0.18 g, 0.38 mmol) and CF3COOH (0.4 mL)
in CH2Cl2 (2 mL) was stirred at 0 °C to room temperature for
2 h. Solvent was evaporated under reduced pressure, and the
resulting salt 10 was dried under high vacuum and used as such
without any further purification.
A solution of 9 (0.17 g, 0.38 mmol), HOBt (0.06 g, 0.45 mmol),
and EDCI (0.08 g, 0.45 mmol) in dry CH2Cl2 (2 mL) was stirred
at 0 °C for 15 min and treated with the above-obtained amine
TFA salt 10 and DIPEA (0.10 mL, 0.57 mmol) under nitrogen
atmosphere for 5 h. Workup as described for 3 and purification
by column chromatography (60-120 mesh silica gel, 1.8%
CH3OH in CHCl3) afforded 4 (0.16 g, 52%) as a white solid:
Experimental Section
The peptides were synthesized following standard solution-
phase peptide coupling methods19 using 1-(3-dimethylamino-
propyl)-3-ethylcarbodiimide hydrochloride (EDCI) and 1-hydroxy-
benzotriazole (HOBt) as coupling agents and dry CH2Cl2 as
solvent. Saponification of tetrapeptide using NaOH in MeOH
gave free acid, and treatment with pentafluorophenol (PFP) in
CH2Cl2 using EDCI as esterification agent gave activated ester.
This activated ester was subjected to Boc deprotection using TFA
in CH2Cl2. The TFA salt of activated ester was taken in CH3CN
(0.01 M) and slow addition into N,N-diisopropylethylamine
(DIPEA; 1.5 equiv) in CH3CN (0.003 M) at 70 °C, after aqueous
workup and chromatographic purification furnished the product
5 in 55% yield.
mp 94-96 °C; [R]20 = þ137.4 (c 0.25 in CHCl3); IR (KBr)
D
3431, 2985, 2934, 1682, 1552, 1456, 1374, 1166, 1082, 1021, 888,
856 cm-1 ; 1H NMR (600 MHz, CDCl3, 278 K) δ 10.32 (s, 1H,
NH-2), 9.89 (s, 1H, NH-4), 7.81 (d, J = 8.2 Hz, 1H, NH-3), 5.91
(d, J = 3.9 Hz, 1H, C1H-3), 5.91 (d, J = 3.9 Hz, 1H, C1H-1),
5.38 (d, J = 7.7 Hz, 1H, NH-1), 4.59 (d, J = 3.9 Hz, 1H, C2H-3),
4.59 (d, J = 3.9 Hz, 1H, C2H-1), 4.54 (m, 1H, CRH-4), 4.48 (m,
1H, CβH-3), 4.30 (m, 1H, C4H-3), 4.28 (m, 1H, CRH-2), 4.26
(m, 1H, C4H-1), 4.21(m, 2H, ethyl ester (-CH2CH3) 4.17
(m, 1H, CβH-1), 3.74 (d, J = 3.3 Hz, 1H, C3H-1), 3.74 (d,
J = 3.3 Hz, 1H, C3H-3), 3.37 (s, 6H, OCH3-1, OCH3-3), 2.50
ꢁ
(m, 1H, CRH-1), 2.50 (m, 1H, CRH-1), 2.48 (m,1H, CRH-3),
Boc-(S)-β-Caa-(R)-Ama-OEt (3). Asolutionofester121 (0.80g,
2.13 mmol) in methanol (4 mL) was treated with aq 4 N NaOH
solution (4 mL) at 0 °C to room temperature. After 2 h, methanol
was removed and adjusted pH to 2-3 with aq 1 N HCl solution at
0 °C and extracted with EtOAc (3 ꢀ 10 mL). The organic layer was
dried (Na2SO4) and concentrated to give 7 (0.71 g, 92%) as a white
solid, which was used for further reaction without any purification.
A solution of acid 7 (0.70 g, 1.93 mmol), HOBt (0.31 g, 2.32
mmol), and EDCI (0.44 g, 2.32 mmol) in CH2Cl2 (5 mL) was
ꢁ
2.48 (m, 1H, CRH-3), 1.50 (s, 6H, acetonide-CH3), 1.48 (m, 3H,
CβH-4), 1.45 (m, 3H, CβH-2), 1.43 (s, 9H, BOC), 1.32 (s, 6H,
acetonide-CH3) 1.30(m, 3H, ethyl ester (-CH2CH3); 13C (150
MHz, CDCl3, 278 K): δ 171.1, 171.7, 169.1, 168.1, 156.5, 111.8,
111.7, 104.8, 104.7, 84.2, 83.9, 82.9, 81.3, 81.2, 80.6, 80.2, 80.0,
79.1, 61.3, 57.5, 57.4, 47.4, 45.9, 36.7, 36.4, 29.6, 29.3, 28.3, 26.7,
26.2, 16.8, 16.2, 14.0; HRMS (ESIþ) m/z calcd for C35H58N4O17
(Mþ þ Na) 829.3694, found 829.3669.
Cyclic-[(S)-β-Caa-(R)-Ama-(S)-β-Caa-(R)-Ama] (5). A solu-
tion of 4 (0.14 g, 0.17 mmol) as described for 7 gave Boc-(S)-
β-Caa-(R)-Ama-(S)-β-Caa-(R)-Ama-OH (11; 0.12 g, 92%) as a
white solid, mp 96-97 0 °C.
(19) (a) Bodanszky, M.; Bodanszky, A. The Practices of Peptide Synthesis;
Springer-Verlag: New York, 1984. (b) Grant, G. A. Synthetic Peptides: A User’s
Guide; W. H. Freeman: New York, 1992. (c) Bodanszky, M. Peptide Chemistry:
A Practical Textbook; Springer-Verlag: Berlin, 1993.
A solution of 11 (0.12 g, 0.16 mmol) was dissolved in CH2Cl2
(4 mL) at 0 °C and treated with pentafluorophenol (0.06 g,
0.32 mmol) and EDCI (0.06 g, 0.32 mmol) sequentially under
nitrogen atmosphere. The resulting solution was stirred at room
(20) Leclair, S.; Baillargeon, P.; Skouta, R.; Gauthier, D.; Zhao, Y.;
Dory, Y. L. Angew. Chem., Int. Ed. 2004, 43, 349–353.
(21) Sharma, G. V. M.; Reddy, V. G.; Reddy, K. R. Tetrahedron:
Asymmetry 2002, 13, 21–24.
J. Org. Chem. Vol. 75, No. 4, 2010 1093